These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27079123)

  • 1. Synthesis and molecular docking of N'-arylidene-5-(4-chlorophenyl)-1-(3,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazides as novel hypoglycemic and antioxidant dual agents.
    Hernández-Vázquez E; Salgado-Barrera S; Ramírez-Espinosa JJ; Estrada-Soto S; Hernández-Luis F
    Bioorg Med Chem; 2016 May; 24(10):2298-306. PubMed ID: 27079123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, hypoglycemic activity and molecular modeling studies of pyrazole-3-carbohydrazides designed by a CoMFA model.
    Hernández-Vázquez E; Aguayo-Ortiz R; Ramírez-Espinosa JJ; Estrada-Soto S; Hernández-Luis F
    Eur J Med Chem; 2013 Nov; 69():10-21. PubMed ID: 23995214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,5-Diarylpyrazole and vanillin hybrids: Synthesis, biological activity and DFT studies.
    Hernández-Vázquez E; Castañeda-Arriaga R; Ramírez-Espinosa JJ; Medina-Campos ON; Hernández-Luis F; Chaverri JP; Estrada-Soto S
    Eur J Med Chem; 2015 Jul; 100():106-18. PubMed ID: 26079087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and subacute antidiabetic studies of ENP-9, a new 1,5-diarylpyrazole derivative.
    Hernández-Vázquez E; Young-Peralta S; Cerón-Romero L; García-Jiménez S; Estrada-Soto S
    J Pharm Pharmacol; 2018 Aug; 70(8):1031-1039. PubMed ID: 29774523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic, antidyslipidemic and toxicity profile of ENV-2: A potent pyrazole derivative against diabetes and related diseases.
    Hernández-Vázquez E; Ocampo-Montalban H; Cerón-Romero L; Cruz M; Gómez-Zamudio J; Hiriart-Valencia G; Villalobos-Molina R; Flores-Flores A; Estrada-Soto S
    Eur J Pharmacol; 2017 May; 803():159-166. PubMed ID: 28322830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor.
    Ali Z; Akhtar MJ; Haider MR; Khan AA; Siddiqui AA; Yar MS
    Bioorg Chem; 2017 Apr; 71():181-191. PubMed ID: 28215601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids.
    Cottineau B; Toto P; Marot C; Pipaud A; Chenault J
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2105-8. PubMed ID: 12127514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents.
    Bansal G; Singh S; Monga V; Thanikachalam PV; Chawla P
    Bioorg Chem; 2019 Nov; 92():103271. PubMed ID: 31536952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes.
    Sagar SR; Agarwal JK; Pandya DH; Dash RP; Nivsarkar M; Vasu KK
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4428-33. PubMed ID: 26372650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents.
    Naim MJ; Alam O; Alam MJ; Hassan MQ; Siddiqui N; Naidu VGM; Alam MI
    Bioorg Chem; 2018 Feb; 76():98-112. PubMed ID: 29169079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Yoshida T; Akahoshi F; Sakashita H; Kitajima H; Nakamura M; Sonda S; Takeuchi M; Tanaka Y; Ueda N; Sekiguchi S; Ishige T; Shima K; Nabeno M; Abe Y; Anabuki J; Soejima A; Yoshida K; Takashina Y; Ishii S; Kiuchi S; Fukuda S; Tsutsumiuchi R; Kosaka K; Murozono T; Nakamaru Y; Utsumi H; Masutomi N; Kishida H; Miyaguchi I; Hayashi Y
    Bioorg Med Chem; 2012 Oct; 20(19):5705-19. PubMed ID: 22959556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
    Kharbanda C; Alam MS; Hamid H; Javed K; Shafi S; Ali Y; Alam P; Pasha MA; Dhulap A; Bano S; Nazreen S; Haider S
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5298-303. PubMed ID: 25442322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Piperine Derivatives with Antidiabetic Effect as PPAR-γ Agonists.
    Kharbanda C; Alam MS; Hamid H; Javed K; Bano S; Ali Y; Dhulap A; Alam P; Pasha MA
    Chem Biol Drug Des; 2016 Sep; 88(3):354-62. PubMed ID: 27037532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and molecular docking studies of novel 3,5-disubstituted 2,4-thiazolidinediones derivatives.
    Ranjan Srivastava A; Bhatia R; Chawla P
    Bioorg Chem; 2019 Aug; 89():102993. PubMed ID: 31129500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves.
    de Sousa E; Zanatta L; Seifriz I; Creczynski-Pasa TB; Pizzolatti MG; Szpoganicz B; Silva FR
    J Nat Prod; 2004 May; 67(5):829-32. PubMed ID: 15165145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and leishmanicidal activities of 1-(4-X-phenyl)-N'-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides.
    Bernardino AM; Gomes AO; Charret KS; Freitas AC; Machado GM; Canto-Cavalheiro MM; Leon LL; Amaral VF
    Eur J Med Chem; 2006 Jan; 41(1):80-7. PubMed ID: 16300859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Docking, Synthesis and Biological Evaluation of Sulphonylureas/ Guanidine Derivatives as Promising Antidiabetic Agent.
    Panchal II; Sen DJ; Patel AD; Shah U; Patel M; Navale A; Bhavsar V
    Curr Drug Discov Technol; 2018; 15(4):315-325. PubMed ID: 28969569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, evaluation and molecular docking of prolyl-fluoropyrrolidine derivatives as dipeptidyl peptidase IV inhibitors.
    Sharma M; Gupta M; Singh D; Kumar M; Kaur P
    Chem Biol Drug Des; 2013 Aug; 82(2):156-66. PubMed ID: 23581745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel thiophenecarbohydrazide, thienopyrazole and thienopyrimidine derivatives as antioxidant and antitumor agents.
    Abu-Hashem AA; El-Shehry MF; Badria FA
    Acta Pharm; 2010 Sep; 60(3):311-23. PubMed ID: 21134865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.